Health / Health News

    HIV Immunotherapy Promising in First Human Study

    NIH | APRIL 22, 2015

    HIV, the virus that causes AIDS, attacks and destroys immune cells. Current treatment with antiretroviral therapy helps to prevent the virus from multiplying. But despite advances in treatment, scientists haven’t yet designed a vaccine that protects people from HIV.


    A team of the Howard Hughes Medical Institute at Rockefeller University has been exploring a different approach. In previous work, they isolated broadly neutralizing antibodies from people and produced them in the lab. These so-called monoclonal antibodies could prevent or treat infection with HIV or its monkey equivalent in mice and macaques.

    The researchers evaluated one of these promising monoclonal anti-HIV antibodies in people. The participants who received the highest dose, however, had significant and rapid decreases in HIV. The virus’s resistance to the antibody was variable.

    This study suggests that 3BNC117 is safe in people and could help to control HIV.




    YOU MAY ALSO LIKE

    US and German scientists say they have evidence that zinc levels may be one of the defining environmental factors that sew the seeds of autism spectrum disorder in babies.
    A team of scientists investigated antimicrobial gene activation during infection to better understand the body’s immune response to microbes.
    A research team has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.
    Vitamin D deficiency has been linked to heart disease and type 2 diabetes. Chronic inflammation plays a role in both of these diseases, and most immune cells have receptors for vitamin D. Binding of vitamin D to its receptor regulates many key processes inside cells.
    Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
    Researchers at the Washington University School of Medicine, St. Louis, and University of Illinois, Urbana-Champaign, created a remote controlled, next-generation tissue implant that allows neuroscientists to inject drugs and shine lights on neurons deep inside the brains of mice.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact